Víctor Claver invests in PhysioMRI, the startup of the first portable MRI machine

Víctor Claver invests in PhysioMRI, the startup of the first portable MRI machine

The basketball world champion and Euroleague player with Valencia Basket, Víctor Claver, has entered as an investor in PhysioMRI, the startup that has created the world’s first portable magnetic resonance device.

The former NBA player joins a list of stars from the world of sports such as Luis Scola or Fernando San Emeterio who have seen a good business opportunity to invest in the field of health linked to sports. “PhysioMRI is a great project that meets the needs of sports clubs for the rapid diagnosis of injuries, and will also allow them to reduce waiting lists in hospitals around the world. Finally, for me trust is important and in this project I I will meet with friends from the world of basketball like San Emeterio and Luis Scola who are also aware of their value in the world in which we operate,” explains Víctor Claver, player for Valencia Basket and the Spanish national team.

For his part, Luis Scola has applauded the entry of the Valencian athlete as an investor in PhysioMRI, in a project that “will have a very positive impact on society and people’s health since it will make magnetic resonance diagnosis available.” . “. of all the world.” Athletes know MRI technology perfectly, as they have used this technique on many occasions but have always had to go to a hospital. With the portable PhysioMRI solution, these machines are 30 times cheaper than the current ones and will be able to have a presence in the medical departments of clubs, physiotherapy clinics or small hospital centers, something that until now was totally impossible. It will revolutionize MRI technology as it is known to date.

Explains Jon Fatelevich, co-founder of the Spanish startup PhysioMRI. A fact as revolutionary as the possibility of democratizing healthcare costs by reducing MRI diagnoses has attracted attention in the sector. The tests carried out in recent weeks show that it can be diagnosed for a price 30 times lower than the current price, and the endorsement of the Higher Council for Scientific Research (CSIC) gives it that halo of a great revolution in the world of health. The first of the PhysioMRI machines are already manufactured and tested on humans, they are in the certification stage and the company estimates that the prevention stage will begin in the first half of 2023.

BACK TO NEWS

 

 

(more…)

The magnetic resonance firm in which Luis Scola invests closes a round of 4 million

The magnetic resonance firm in which Luis Scola invests closes a round of 4 million

The Valencian startup PhysioMRI , which has developed low-field magnetic resonance medical technology, has closed an investment and financing round of 4 million euros . An injection in which it has obtained funds from the Horizon Europe program of the European Union, in addition to the CDTI of the Ministry of Science and Innovation and the Valencian Institute of Finance (IVF), together with previous investors, which include personalities from the world of sport and technology.

Among the investors who are part of the shareholders are recognized basketball figures, such as former NBA players Luis Scola or Víctor Claver . Prestigious businessmen such as Jorge Alonso, Javier Lopezosa, or the Fernández Serosa brothers are also part of it, all of them with experience in the world of sports, the distribution of medical devices and investment in technology, according to the company itself.

PhysioMRI already has a team in operation at the facilities of the Hospital La Fe in Valencia, under a collaboration agreement to improve neural networks and image processing. The company is a leader in the development of low-field MRI devices, priced up to 20 times lower than current devices .

Jon Fatelevich, co-founder of PhysioMRI and leader of the financing and commercialization strategy, explained that “this investment round will allow us to fulfill our ambitious roadmap. In the next 18 months, we will complete CE and FDA certifications and begin manufacturing. of the first generation of our MRI machines.

The company’s intention is to begin selling its product this year, although the first deliveries will be long-term. “The interest from clinics, doctors and even distributors is extraordinary, and in 2023 we will begin the commercialization of our devices, with an estimated delivery date for early 2025,” he explains. This technology has the potential to reduce the cost of testing for patients by 70%.

BACK TO NEWS

 

 

(more…)